Clinical Trial: A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)

U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07561294) titled 'A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)' on April 24.

Brief Summary: This clinical study will evaluate the safety, reactogenicity, and immunogenicity of monovalent mRNA-1982, a messenger ribonucleic acid (mRNA) vaccine to prevent Lyme disease in healthy adults aged 18 to 70 years old.

Study Start Date: April 27

Study Type: INTERVENTIONAL

Condition: Lyme Disease

Intervention: BIOLOGICAL: mRNA-1982

Suspension for injection

BIOLOGICAL: Placebo

Suspension for injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: M...